| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |